Ultragenyx Pharmaceutical Inc.

GW&K Investment Management, LLC RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

1,375,407

Value ($000)

31,634

Weight

0.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	31,634	0.3%	1,375,407	12/31/2025
2025 Q3	11/12/2025	34,597	0.3%	1,150,169	9/30/2025
2025 Q2	8/11/2025	17,500	0.2%	481,288	6/30/2025